BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28349125)

  • 1. Application of Operational Tolerance Signatures Are Limited by Variability and Type of Immunosuppression in Renal Transplant Recipients: A Cross-Sectional Study.
    Bottomley MJ; Chen M; Fuggle S; Harden PN; Wood KJ
    Transplant Direct; 2017 Jan; 3(1):e125. PubMed ID: 28349125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fingerprints of transplant tolerance suggest opportunities for immunosuppression minimization.
    Sarwal MM
    Clin Biochem; 2016 Mar; 49(4-5):404-10. PubMed ID: 26794635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression signature of tolerance and lymphocyte subsets in stable renal transplants: results of a cross-sectional study.
    Moreso F; Torres IB; Martínez-Gallo M; Benlloch S; Cantarell C; Perelló M; Jimeno J; Pujol-Borrell R; Seron D
    Transpl Immunol; 2014 Jun; 31(1):11-6. PubMed ID: 24810779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA antigen frequencies in renal transplant recipients and non-immunosuppressed patients with non-melanoma skin cancer.
    Glover MT; Bodmer J; Bodmer W; Kennedy LJ; Brown J; Navarrete C; Kwan JT; Leigh IM
    Eur J Cancer; 1993; 29A(4):520-4. PubMed ID: 8435203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.
    Niu Q; Mendoza Rojas A; Dieterich M; Roelen DL; Clahsen-van Groningen MC; Wang L; van Gelder T; Hesselink DA; van Besouw NM; Baan CC
    Front Immunol; 2020; 11():1972. PubMed ID: 32983131
    [No Abstract]   [Full Text] [Related]  

  • 7. ASSOCIATION BETWEEN DE NOVO DONOR SPECIFIC HLA ANTIBODY, C4D STAINING IN RENAL GRAFT BIOPSY AND GRAFT OUTCOME: A SINGLE CENTER EXPERIENCE.
    Cicciarelli J; Cho YW; Koss M; Helstab-Houston K; Mendez R; Kasahara N; Hutchinson IV; Shah T
    J Nephrol Ren Transplant; 2009; 2(2):69-74. PubMed ID: 22514590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the immunogenicity of Dukoral® oral cholera vaccine between renal transplant recipients on either a calcineurin inhibitor or mycophenolate - A controlled trial.
    Jonker EFF; Uijlings MAC; Visser LG; Soonawala D
    Vaccine; 2019 May; 37(23):3133-3139. PubMed ID: 31029516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The presence of donor-specific human leukocyte antigen antibodies does not preclude successful withdrawal of tacrolimus in stable renal transplant recipients.
    Kreijveld E; Hilbrands LB; van Berkel Y; Joosten I; Allebes W
    Transplantation; 2007 Nov; 84(9):1092-6. PubMed ID: 17998862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More epidermal p53 patches adjacent to skin carcinomas in renal transplant recipients than in immunocompetent patients: the role of azathioprine.
    de Graaf YG; Rebel H; Elghalbzouri A; Cramers P; Nellen RG; Willemze R; Bouwes Bavinck JN; de Gruijl FR
    Exp Dermatol; 2008 Apr; 17(4):349-55. PubMed ID: 17979968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell reactivity during tapering of immunosuppression to low-dose monotherapy prednisolone in HLA-identical living-related renal transplant recipients.
    Gerrits JH; van de Wetering J; Weimar W; van Besouw NM
    Transplantation; 2009 Mar; 87(6):907-14. PubMed ID: 19300195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Multicenter Experience of Immunosuppression Minimization Among 661 Liver Transplant Recipients.
    Aguiar D; Martínez-Urbistondo D; Baroja-Mazo A; de la Mata M; Rodríguez-Perálvarez M; Rubín A; Puchades L; Serrano T; Montero J; Cuadrado A; Casafont F; Salcedo M; Rincón D; Pons JA; Herrero JI
    Ann Transplant; 2017 May; 22():265-275. PubMed ID: 28461684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring predicted indirectly recognizable HLA epitopes (PIRCHE-II) in liver transplant recipients on calcineurin inhibitor-free maintenance immunosuppression. A retrospective single center study.
    Meszaros M; Niemann M; Ursic-Bedoya J; Faure S; Meunier L; Rivière B; Costes-Martineau V; Thevenin C; Pageaux GP
    Transpl Immunol; 2020 Apr; 59():101272. PubMed ID: 32061667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression in liver transplant.
    Di Maira T; Little EC; Berenguer M
    Best Pract Res Clin Gastroenterol; 2020; 46-47():101681. PubMed ID: 33158467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From immunosuppression to tolerance.
    Adams DH; Sanchez-Fueyo A; Samuel D
    J Hepatol; 2015 Apr; 62(1 Suppl):S170-85. PubMed ID: 25920086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a B cell signature associated with renal transplant tolerance in humans.
    Newell KA; Asare A; Kirk AD; Gisler TD; Bourcier K; Suthanthiran M; Burlingham WJ; Marks WH; Sanz I; Lechler RI; Hernandez-Fuentes MP; Turka LA; Seyfert-Margolis VL;
    J Clin Invest; 2010 Jun; 120(6):1836-47. PubMed ID: 20501946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitors affect circulating regulatory T cells in stable renal transplant recipients.
    San Segundo D; Ruiz JC; Fernández-Fresnedo G; Izquierdo M; Gómez-Alamillo C; Cacho E; Benito MJ; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplant Proc; 2006 Oct; 38(8):2391-3. PubMed ID: 17097943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
    Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
    Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.